{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:06:43Z","timestamp":1783922803951,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373968"],"award-info":[{"award-number":["82373968"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274018"],"award-info":[{"award-number":["82274018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2024ZY01047"],"award-info":[{"award-number":["2024ZY01047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118078","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:19:10Z","timestamp":1778944750000},"page":"118078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Sotorasib induces intestinal epithelial injury through suppression of the cAMP\/PKA\/CREB signaling axis"],"prefix":"10.1016","volume":"251","author":[{"given":"Jiajia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118078_b0005","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s40265-021-01574-2","article-title":"Sotorasib: first approval","volume":"81","author":"Blair","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2026.118078_b0010","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1200\/JCO.22.02524","article-title":"Long-term outcomes and molecular correlates of sotorasib efficacy in patients with pretreated KRAS G12C-mutated non\u2013small-cell lung cancer: 2-year analysis of CodeBreaK 100","volume":"41","author":"Dy","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118078_b0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(23)00221-0","article-title":"Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial","volume":"401","author":"de Langen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2026.118078_b0020","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1200\/JCO-24-02026","article-title":"Overall survival analysis of the phase III CodeBreaK 300 study of sotorasib plus panitumumab versus investigator\u2019s choice in chemorefractory KRAS G12C colorectal cancer","volume":"43","author":"Pietrantonio","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118078_b0025","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","article-title":"KRASG12C inhibition with sotorasib in advanced solid tumors","volume":"383","author":"Hong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118078_b0030","first-page":"470","article-title":"Sotorasib effective in KRAS-mutant NSCLC","volume":"18","author":"Sidaway","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118078_b0035","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf153","article-title":"KRAS mutated NSCLC: past, present, and future directions in a rapidly evolving landscape","volume":"30","author":"Frisch","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.bcp.2026.118078_b0040","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyae356","article-title":"Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer","volume":"30","author":"Skoulidis","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.bcp.2026.118078_b0045","doi-asserted-by":"crossref","unstructured":"Y. Zhang, S. Tong, L. Wan, Two first-generation KRAS inhibitor safety profiles: a disproportionality analysis of individual reports from the FDA adverse event reporting system. Expert Opin. Drug Saf., n.d.;0:1\u201311. https:\/\/doi.org\/10.1080\/14740338.2025.2499219.","DOI":"10.1080\/14740338.2025.2499219"},{"key":"10.1016\/j.bcp.2026.118078_b0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0300-483X(00)00314-0","article-title":"Neurochemistry and neuropharmacology of emesis - the role of serotonin","volume":"153","author":"Endo","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2026.118078_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114644","article-title":"Review on the effect of chemotherapy on the intestinal barrier: epithelial permeability, mucus and bacterial translocation","volume":"162","author":"Dahlgren","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118078_b0060","doi-asserted-by":"crossref","first-page":"648","DOI":"10.7150\/jca.99421","article-title":"Important role of intestinal microbiota in chemotherapy-induced diarrhea and therapeutics","volume":"16","author":"Jiang","year":"2025","journal-title":"J. Cancer"},{"key":"10.1016\/j.bcp.2026.118078_b0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/SPC.0b013e32835f3e8c","article-title":"Chemotherapy-induced mucosal barrier dysfunction: an updated review on the role of intestinal tight junctions","volume":"7","author":"Wardill","year":"2013","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.bcp.2026.118078_b0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40164-020-00191-1","article-title":"Complex roles of cAMP\u2013PKA\u2013CREB signaling in cancer","volume":"9","author":"Zhang","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.118078_b0075","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/ki.2011.95","article-title":"Intracellular cAMP signaling by soluble adenylyl cyclase","volume":"79","author":"Tresguerres","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2026.118078_b0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/er.2013-1053","article-title":"Clinical and molecular genetics of the phosphodiesterases (PDEs)","volume":"35","author":"Azevedo","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2026.118078_b0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/328175a0","article-title":"Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene","volume":"328","author":"Montminy","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118078_b0090","doi-asserted-by":"crossref","first-page":"19872","DOI":"10.1074\/jbc.M701435200","article-title":"DNA binding and phosphorylation induce conformational alterations in the kinase-inducible domain of CREB: implications for the mechanism of transcription function *","volume":"282","author":"Sharma","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118078_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031532","article-title":"Formulation studies with cyclodextrins for novel selenium NSAID derivatives","volume":"25","author":"Ramos-Inza","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118078_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17030288","article-title":"Cyclodextrins: Enhancing drug delivery, solubility and bioavailability for modern therapeutics","volume":"17","author":"Nicolaescu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2026.118078_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/ph17060737","article-title":"Evaluation of solubility, dissolution rate, and oral bioavailability of \u03b2-cyclodextrin and hydroxypropyl \u03b2-cyclodextrin as inclusion complexes of the tyrosine kinase inhibitor, alectinib","volume":"17","author":"Majeed","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bcp.2026.118078_b0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S2468-1253(22)00241-2","article-title":"The intestinal barrier in disorders of the central nervous system","volume":"8","author":"Pellegrini","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2026.118078_b0115","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2542385","article-title":"Using MUC2 mucin producing tumorigenic human goblet-like cells to uncover functional properties of the mucus barrier","volume":"17","author":"Gorman","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bcp.2026.118078_b0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.MIB.0000217334.30689.3e","article-title":"Regulation of apoptosis during homeostasis and disease in the intestinal epithelium","volume":"12","author":"Edelblum","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bcp.2026.118078_b0125","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/toxins17110534","article-title":"Mycotoxins and the intestinal epithelium: from barrier injury to stem cell dysfunction","volume":"17","author":"Huo","year":"2025","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bcp.2026.118078_b0130","doi-asserted-by":"crossref","DOI":"10.1177\/1534735420928493","article-title":"Diarrhea induced by small molecule tyrosine kinase inhibitors compared with chemotherapy: potential role of the microbiome","volume":"19","author":"Secombe","year":"2020","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.bcp.2026.118078_b0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/toxres\/tfab026","article-title":"Epidermal growth factor receptor inhibitor-induced diarrhea: Clinical incidence, toxicological mechanism, and management","volume":"10","author":"Tao","year":"2021","journal-title":"Toxicol. Res. (Camb)"},{"key":"10.1016\/j.bcp.2026.118078_b0140","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1677\/jme.1.01535","article-title":"cAMP-dependent protein kinase activation inhibits proliferation and enhances apoptotic effect of tumor necrosis factor-alpha in NCI-H295R adrenocortical cells","volume":"33","author":"Liu","year":"2004","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2026.118078_b0145","doi-asserted-by":"crossref","first-page":"16115","DOI":"10.1038\/s41598-018-34421-8","article-title":"Functional polarization of human hepatoma HepaRG cells in response to forskolin","volume":"8","author":"Mayati","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118078_b0150","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/0008-5472.CAN-06-0249","article-title":"Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein","volume":"68","author":"Aggarwal","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118078_b0155","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1158\/0008-5472.CAN-07-5376","article-title":"Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer","volume":"68","author":"Seo","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118078_b0160","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s11427-022-2108-x","article-title":"CREB1 contributes colorectal cancer cell plasticity by regulating lncRNA CCAT1 and NF-\u03baB pathways","volume":"65","author":"Li","year":"2022","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.bcp.2026.118078_b0165","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1541-7786.MCR-14-0590","article-title":"Colorectal carcinogenesis: connecting K-RAS-induced transformation and CREB activity in vitro and in vivo","volume":"13","author":"Steven","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118078_b0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118078_b0175","doi-asserted-by":"crossref","unstructured":"Identification of the clinical development candidate MRTX849, a covalent KRASG12C inhibitor for the treatment of cancer. J. Med. Chem., 2020;63:6679\u201393. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b02052.","DOI":"10.1021\/acs.jmedchem.9b02052"},{"key":"10.1016\/j.bcp.2026.118078_b0180","doi-asserted-by":"crossref","first-page":"15386","DOI":"10.1021\/acs.jmedchem.4c03183","article-title":"Discovery of fulzerasib (GFH925) for the treatment of KRAS G12C-mutated solid tumors","volume":"68","author":"Jiang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118078_b0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8290.CD-19-1167","article-title":"The KRASG12C inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients","volume":"10","author":"Hallin","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2026.118078_b0190","doi-asserted-by":"crossref","unstructured":"Y. Yuan, Y. Deng, Y. Jin, et al. Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRASG12C inhibitor-na\u00efve Chinese patients with KRASG12C-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studies. Signal Transduction and Targeted Therapy 2025;10. https:\/\/doi.org\/10.1038\/s41392-025-02315-7.","DOI":"10.1038\/s41392-025-02315-7"},{"key":"10.1016\/j.bcp.2026.118078_b0195","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12964-025-02425-3","article-title":"Off-target engagement of sotorasib with PPAR\u03b3 via FABP4: a novel mechanism driving interstitial lung disease","volume":"23","author":"Zhang","year":"2025","journal-title":"Cell Commun. Signaling"},{"key":"10.1016\/j.bcp.2026.118078_b0200","doi-asserted-by":"crossref","first-page":"35454","DOI":"10.18632\/oncotarget.7721","article-title":"Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target","volume":"7","author":"Steven","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.118078_b0205","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1038\/oncsis.2014.21","article-title":"Selective CREB-dependent cyclin expression mediated by the PI3K and MAPK pathways supports glioma cell proliferation","volume":"3","author":"Daniel","year":"2014","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bcp.2026.118078_b0210","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1038\/s41598-018-23199-4","article-title":"Dual role of CREB in the regulation of VSMC proliferation: mode of activation determines pro- or anti-mitogenic function","volume":"8","author":"Hudson","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118078_b0215","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3727\/096504016X14634208142987","article-title":"Downregulation of CREB promotes cell proliferation by mediating G1\/S phase transition in hodgkin lymphoma","volume":"24","author":"Lu","year":"2016","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bcp.2026.118078_b0220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.2002.tb04326.x","article-title":"Reinventing the wheel of cyclic AMP: Novel mechanisms of cAMP signaling","volume":"968","author":"Chin","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2026.118078_b0225","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41401-023-01081-y","article-title":"TGR5 agonist inhibits intestinal epithelial cell apoptosis via cAMP\/PKA\/c-FLIP\/JNK signaling pathway and ameliorates dextran sulfate sodium-induced ulcerative colitis","volume":"44","author":"Yang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2026.118078_b0230","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1748-1716.2011.02273.x","article-title":"Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger","volume":"204","author":"Insel","year":"2012","journal-title":"Acta Physiol (Oxf.)"},{"key":"10.1016\/j.bcp.2026.118078_b0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/374421a0","article-title":"Adenylyl cyclases and the interaction between calcium and cAMP signalling","volume":"374","author":"Cooper","year":"1995","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2026.118078_b0240","first-page":"S252","article-title":"Phosphodiesterase inhibitors","volume":"147","author":"Boswell-Smith","year":"2006","journal-title":"Br. J. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:25:34Z","timestamp":1783920334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226004132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S0006295226004132"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118078","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sotorasib induces intestinal epithelial injury through suppression of the cAMP\/PKA\/CREB signaling axis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118078"}}